Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia;Intérêt pharmacodynamique de la perfusion continue vs l'administration intermittente de ceftazidime dans les pneumonies nosocomiales sévères

Pathologie Biologie

Volumn 53, Issue 8-9, 2005, Pages 546-550

  Cousson, J ^a   Floch, T ^a   Vernet Garnier, V ^a   Appriou, M ^a   Petit, J S ^a   Jovenin, N ^b   Lamiable, D ^c   Hoizey, G ^c  

^a SERVICE DE DERMATOLOGIE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c HÔPITAL MAISON BLANCHE   (France)

Author keywords

Ceftazidime; Continuous infusion; Intensive care; Nosocomial pneumoniae; Pharmacodynamic

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTAZIDIME;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MALE; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CROSS INFECTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PNEUMONIA; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME;

EID: 27444432358     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2005.06.002     Document Type: Article

References (13)

1. B. Schlemmer Ŕanimation ḿdicale 2001 Masson Paris
2. e Jourńes internationales de Mises au point en anesth́sie-ŕanimation (MAPAR) 2000 625 631 (Juin; Paris)
3. W.A. Craig, and S.C. Ebert Continuous infusion of beta-lactam antibiotics Antimicrob. Agents Chemother. 36 1992 2577 2583
4. C.M. Chidiac, and F. Leblanc Distribution pulmonaire de la ceftazidime:: impact du mode d'administration et rôle de l'administration intraveineuse en continu Antibiotiques 4 2002 2S29 2S35
5. A.S. Benko, D.M. Cappellety, J.A. Kruse, and M.J. Ryback Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected Gram negative infections Antimicrob. Agents Chemother. 40 1996 691 695
6. J.W. Mouton, and J.G. Den Hollander Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model Antimicrob. Agents Chemother. 38 1994 931 936
7. D.P. Nicolau, J.C. MacNabb, M.K. Lacy, J. Li, R. Quintiliani, and C.H. Nightingale Pharmacokinetics and pharmacodynamics of continuous and intermittent ceftazidime during the treatment of nosocomial pneumonia Clin. Drug. Invest. 18 1999 133 139
8. S.D. Hanes, G.C. Wodd, V. Herring, M.A. Croce, T.C. Fabian, and E. Pritchard Am. J. Surg. 179 2000 436 440
9. J.M. Hyatt, P.S. McKinnon, G.S. Zimmer, and J.J. Schentag The importance of pharmacokinetic-pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents Clin. Pharmacokinet. 28 2 1995 143 160
10. e Journée de l'Hôpital Claude-Bernard, 19 novembre 2004;Paris.
11. R. Garraffo Bases pharmacodynamiques de l'administration iv des b̂talactamines par perfusion continue:: optimisation de l'activit́ antibact́rienne sur les bact́ries ̀ Gram ńgatif Antibiotiques 4 2002 2S29 2S35
12. D.P. Nicolau, J.C. McNabb, M.K. Lacy, R. Quintiliani, and C.H. Nightingale Continuous vs intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumoniae Int. J. Antimicrob. Agents 17 2001 497 504
13. J. Lipman, C.D. Gomersall, T. Gin, G.M. Joynt, and R.J. Young Continuous infusion ceftazidime in intensive care: a randomized controlled trial J. Antimicrob. Chemother. 43 1999 309 311